GLOBAL BIO-CHEM (00809) has released its annual performance, with an annual profit of HK$156 million, a decrease of 79.69% year-on-year.

GLOBAL BIO-CHEM (00809) announced its annual results for the year ended December 31, 2025, with the group achieving revenue of HK$2.279 billion, an increase of 13.86% year-on-year. The net profit for the year was HK$156 million, a decrease of 79.69% year-on-year. Basic earnings per share were 1.4 HK cents. The announcement stated that during most of the year, due to intense competition in the domestic market, the group maximized the production capacity of its amino acid business facilities, resulting in an increase in sales of approximately 36.6% to 522,000 metric tons (2024: 382,000 metric tons). However, starting from the second half of 2025, the European Union and the United States imposed final anti-dumping duties on China's lysine products and initiated anti-subsidy tax investigations. As a result, local suppliers began reselling amino acid products in the domestic market, and in response to the oversupply of Chinese amino acid products, the group adjusted its amino acid production in the fourth quarter of 2025 to achieve optimal production capacity.